1. DeGruttola, V., L. Dix, R. D'Aquila, D. Holder, A. Phillips, M. Ait-Khaled, J. Baxter, P. Clevenbergh, S. Hammer, R. Harrigan, D. Katzenstein, R. Lanier, M. Miller, M. Para, S. Yerly, A. Zolopa, J. Murray, A. Patick, V. Miller, S. Castillo, L. Pedneault, and J. Mellors. 2000. The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir. Ther.5:41-48.
2. Kijak, G. H., A. E. Rubio, S. E. Pampuro, C. Zala, P. Cahn, R. Galli, J. S. Montaner, and H. Salomon. 2003. Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms. HIV Med.4:72-78.
3. Meynard, J. L., M. Vray, L. Morand-Joubert, E. Race, D. Descamps, G. Peytavin, S. Matheron, C. Lamotte, S. Guiramand, D. Costagliola, F. Brun-Vizinet, F. Clavel, and P.-M. Girard. 2002. Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial. AIDS16:727-736.
4. Puchhammer-Stockl, E., C. Steininger, E. Geringer, and F. X. Heinz. 2002. Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains. HIV Med.3:200-206.
5. Ravela, J., B. J. Betts, F. Brun-Vezinet, A. M. Vandamme, D. Descamps, K. Van Loethem, K. Smith, J. M. Shapiro, D. Winslow, C. Reid, and R. W. Shafer. 2003. HIV-1 protease and reverse transcriptase mutation patterns causing discordances between drug resistance interpretation algorithms. J. Acquir. Immun. Defic. Syndr.33:8-14.